Adagene

+$0.02 (+0.17%) Today
-$0.14 (-1.18%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adagene and other ETFs, options, and stocks.

About ADAG

Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.

CEO
Pei Zhi Luo
Employees
198
Headquarters
Suzhou, Jiangsu
Founded
2011

ADAG Key Statistics

Market Cap
514.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
25.53K
High Today
$11.84
Low Today
$11.50
Open Price
$11.68
Volume
9.67K
52 Week High
$31.83
52 Week Low
$10.88

ADAG Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Mar 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure